眼科影像設備管道 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者(2024 年版)
市場調查報告書
商品編碼
1494233

眼科影像設備管道 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者(2024 年版)

Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 46 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

本報告提供了有關眼科成像設備產品線的全面信息,包括處於不同開發階段的產品的比較分析以及正在進行的臨床試驗的數據。

目錄

第 1 章目錄

第 2 章簡介

第三章開發中的產品

  • 眼科影像設備 - 管道產品:依開發階段劃分
  • 眼科影像設備 - 管道產品:依地區
  • 眼科影像設備 - 管道產品:依監管途徑
  • 眼科影像設備 - 管道產品:依預計核准日期

第 4 章眼科影像設備 - 各公司正在開發的管道產品

  • 眼科影像設備公司 - 管道產品:依發展階段劃分
  • 眼科影像設備 - 管道產品:依開發階段劃分

第五章眼科影像設備製造商及產品概論

  • 先進醫療電子公司:公司概況
    • Advanced Medical Electronics Corp:管道產品和正在進行的臨床試驗概述
  • Ai-Ris LLC:公司概況
    • Ai-Ris LLC:管道產品和正在進行的臨床試驗概述
  • Al.chi.mi.a.Srl:公司概況
    • Al.chi.mi.a. Srl:管道產品和正在進行的臨床試驗概述
  • 香港城市大學:公司概況
    • 香港城市大學:管道產品和正在進行的臨床試驗概述
  • 哥倫比亞大學:公司概況
    • 哥倫比亞大學:管道產品和正在進行的臨床試驗概述
  • IDCP Scotland Ltd:公司概況
    • IDCP Scotland Ltd:管道產品和正在進行的臨床試驗概述
  • JuneBrain, LLC:公司概況
    • JuneBrain, LLC:管道產品和正在進行的臨床試驗概述
  • L.V. Prasad 眼科研究所:公司概況
    • L.V. Prasad 眼科研究所:管道產品和正在進行的臨床試驗概述
  • 徠卡顯微系統有限公司:公司概況
    • Leica Microsystems GmbH:管道產品和正在進行的臨床試驗概述
  • Novai Ltd:公司概況
    • Novai Ltd:管道產品和正在進行的臨床試驗概述
  • Physical Sciences Inc:公司概況
    • Physical Sciences Inc:管道產品和正在進行的臨床試驗概述
  • RetinaScope BV:公司概況
    • RetinaScope BV:管道產品和正在進行的臨床試驗概述
  • 新加坡眼科研究所:公司概況
    • 新加坡眼科研究所:管道產品和正在進行的臨床試驗概述
  • Spring Vision Ltd:公司概況
    • Spring Vision Ltd:管道產品和正在進行的臨床試驗概述
  • TeleMedC Pte Ltd:公司概況
    • TeleMedC Pte Ltd:管道產品和正在進行的臨床試驗概述
  • 南佛羅里達大學:公司概況
    • 南佛羅里達大學:管道產品和正在進行的臨床試驗概述

第 6 章眼科影像設備 - 最新進展

  • 2024 年 5 月 8 日:ContextVision 發佈 2024 年第一季中期報告
  • 2024 年 5 月 7 日:Optomed 發佈 2024 年 1 月至 3 月中期報告
  • 2024 年 4 月 15 日:Bausch + Lomb 於 5 月 1 日公佈 2024 年第一季業績
  • 2024 年 4 月 12 日:ContextVision 發佈 2023 年年度報告
  • 2024 年 3 月 1 日:Molecular Partners 召開電話會議,討論 2023 年第四季和全年業績,並宣佈即將舉行的投資者介紹會
  • 2024 年 2 月 15 日:Gland Pharma 第三季財務業績,淨利 192 億盧比,銷售額 1,545 億盧比
  • 2024 年 2 月 15 日:Optomed 發佈 2023 年 1 月至 12 月的初步財務報表
  • 2024 年 2 月 14 日:Gland Pharma 發佈截至 2023 年 12 月 31 日的季度和九個月未經審計的財務業績
  • 2023 年 11 月 3 日:Optomed 發佈 2023 年 1 月至 9 月中期報告
  • 2023 年 10 月 26 日:ContextVision 公佈第三季業績
  • 2023 年 8 月 28 日:ContextVision 任命 Richard Hallstrom 為財務長
  • 2023 年 8 月 24 日:ContextVision 公佈強勁的第二季業績,獲利穩健成長
  • 2023 年 8 月 3 日:Juho Himberg 被任命為 Optomed 首席執行官

第七章附錄

Product Code: GDME1745EPD

GlobalData's Medical Devices sector report, "Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Ophthalmic Imaging Equipment Overview

3 Products under Development

  • 3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • 3.2 Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • 3.3 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • 3.4 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date

4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies

  • 4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
  • 4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development

5 Ophthalmic Imaging Equipment Companies and Product Overview

  • 5.1 Advanced Medical Electronics Corp Company Overview
    • 5.1.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Ai-Ris LLC Company Overview
    • 5.2.1 Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Al.chi.mi.a. Srl Company Overview
    • 5.3.1 Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 City University of Hong Kong Company Overview
    • 5.4.1 City University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Columbia University Company Overview
    • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 IDCP Scotland Ltd Company Overview
    • 5.6.1 IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 JuneBrain, LLC Company Overview
    • 5.7.1 JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 L.V. Prasad Eye Institute Company Overview
    • 5.8.1 L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Leica Microsystems GmbH Company Overview
    • 5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Novai Ltd Company Overview
    • 5.10.1 Novai Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Physical Sciences Inc Company Overview
    • 5.11.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 RetinaScope BV Company Overview
    • 5.12.1 RetinaScope BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Singapore Eye Research Institute Company Overview
    • 5.13.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Spring Vision Ltd Company Overview
    • 5.14.1 Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 TeleMedC Pte Ltd Company Overview
    • 5.15.1 TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 University of South Florida Company Overview
    • 5.16.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

6 Ophthalmic Imaging Equipment- Recent Developments

  • 6.1 May 08, 2024: ContextVision Releases Q1 Interim Report 2024
  • 6.2 May 07, 2024: Optomed Announces Interim Report, January - March 2024
  • 6.3 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
  • 6.4 Apr 12, 2024: ContextVision Releases Annual Report for Fiscal Year 2023
  • 6.5 Mar 01, 2024: Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
  • 6.6 Feb 15, 2024: Gland Pharma Q3 Results: Net porfit at Rs 192 cr, Revenue at Rs 1545 cr
  • 6.7 Feb 15, 2024: Optomed Announces Financial Statements Bulletin, January - December 2023
  • 6.8 Feb 14, 2024: Gland Pharma Announces Unaudited Financial Results for Quarter and Nine Months Ended December 31, 2023
  • 6.9 Nov 03, 2023: Optomed Announces Interim Report, January - September 2023
  • 6.10 Oct 26, 2023: ContextVision Reports Q3 Results
  • 6.11 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer
  • 6.12 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth
  • 6.13 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Visual Imaging System - Product Status
  • Visual Imaging System - Product Description
  • Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Portable Retinal Imaging System - Product Status
  • Portable Retinal Imaging System - Product Description
  • Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview
  • Vitreous Visualization Device - Product Status
  • Vitreous Visualization Device - Product Description
  • City University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • SLD-PAM System - Product Status
  • SLD-PAM System - Product Description
  • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Smartphone Retinal Imaging Camera - Product Status
  • Smartphone Retinal Imaging Camera - Product Description
  • IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 3D Eye Scanner - Product Status
  • 3D Eye Scanner - Product Description
  • JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Neuro-i SS-OCT - Product Status
  • Neuro-i SS-OCT - Product Description
  • L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Pediatric Perimeter - Product Status
  • Pediatric Perimeter - Product Description
  • Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Forveo - Product Status
  • Forveo - Product Description
  • Novai Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • AI System - Age-Related Macular Degeneration - Product Status
  • AI System - Age-Related Macular Degeneration - Product Description
  • Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Ophthalmic Imaging Instrument - Product Status
  • Ophthalmic Imaging Instrument - Product Description
  • Optics Imaging System - Alzheimer's Disease - Product Status
  • Optics Imaging System - Alzheimer's Disease - Product Description
  • RetinaScope BV Pipeline Products & Ongoing Clinical Trials Overview
  • 3D Eye Imaging Device - Product Status
  • 3D Eye Imaging Device - Product Description
  • Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Non-Invasive Imaging Tool - Product Status
  • Non-Invasive Imaging Tool - Product Description
  • Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • iCapture 45 - Product Status
  • iCapture 45 - Product Description
  • Next-Generation iCapture 45 - Product Status
  • Next-Generation iCapture 45 - Product Description
  • TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • EyeScan R2 - Product Status
  • EyeScan R2 - Product Description
  • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Ophthalmic Imaging System - Product Status
  • Ophthalmic Imaging System - Product Description
  • Glossary

List of Figures

  • Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
  • Ophthalmic Imaging Equipment - Pipeline Products by Territory
  • Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
  • Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date